CALL/ABBOTT LABORATORIES/160/0.1/20.09.24 Stock

Warrant

DE000GQ9GJZ9

Market Closed - BOERSE MUENCHEN 02:26:46 2024-05-24 pm EDT
0.011 EUR 0.00% Intraday chart for CALL/ABBOTT LABORATORIES/160/0.1/20.09.24
Current month+83.33%
1 month+37.50%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-24 0.011 0.00%
24-05-23 0.011 +22.22%
24-05-22 0.009 0.00%
24-05-21 0.009 0.00%
24-05-20 0.009 0.00%

Real-time BOERSE MUENCHEN

Last update May 24, 2024 at 02:26 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer Goldman Sachs
WKN GQ9GJZ
ISINDE000GQ9GJZ9
Date issued 2024-02-19
Strike 160 $
Maturity 2024-09-20 (119 Days)
Parity 10 : 1
Emission price 0.01
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.023
Lowest since issue 0.003
Spread 0.02
Spread %66.67%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104 USD
Average target price
125.7 USD
Spread / Average Target
+20.92%
Consensus